Skip to main content
. 2023 Jun 1;6(8):e202301902. doi: 10.26508/lsa.202301902

Table 1.

Serum data of miR-33b−/− and miR-33b+/+ mice fed a 45% HFD.

miR-33b−/− miR-33b+/+
TP (g/dl) 5.00 ± 0.08 4.81 ± 0.13
ALB (g/dl) 3.16 ± 0.05 3.13 ± 0.08
AST (IU/l) 46.3 ± 2.9 91.3 ± 15.6 **
ALT (IU/l) 26.2 ± 4.3 60.6 ± 14.1 *
ALP (IU/l) 157.6 ± 8.3 213.1 ± 14.5 **
LDH (IU/l) 492.7 ± 81.4 563.1 ± 101.6
T-BIL (mg/dl) 0.074 ± 0.007 0.175 ± 0.043 *
T-Cho (mg/dl) 164.5 ± 6.6 84.40 ± 11.3 ***
LDL-C (mg/dl) 12.3 ± 1.3 6.7 ± 0.6 **
HDL-C (mg/dl) 77.6 ± 1.0 46.4 ± 5.6 ***
TG (mg/dl) 18.3 ± 1.8 10.9 ± 1.0 **
NEFA (μEq/l) 612.1 ± 34.2 602.7 ± 44.1
CRE (mg/dl) 0.09 ± 0.007 0.08 ± 0.004
BUN (mg/dl) 17.6 ± 0.57 16.9 ± 0.58

Male mice were fed a 45% HFD from the age of 8 wk for 12 wk. Values are the mean ± S.E.M., n = 10, 11 each; *P < 0.05, **P < 0.01, ***P < 0.001, unpaired t test.